Immunotherapy in early triple-negative breast cancer: International study provides important insights for more precise patient selection
Scientific presentations at the 45th Annual Congress of the German Society of Senology in Munich
Prof. Dr. med. Sibylle Loibl spoke about the future of drug evaluation and the challenges of creating an innovation-friendly and patient-centered healthcare system.
This year, GBG is represented at the DKK with three scientific posters, presenting current results from its study activities.
At the 48th San Antonio Breast Cancer Symposium 2025 GBG is taking part in the following presentations.
